Clinical Trial Update: Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating a cancer vaccine therapy in combination with pembrolizumab for advanced fallopian tube, primary peritoneal, or ovarian …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Vaccine therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma | Phase 1, Phase 2 | Status: RECRUITING